Steven Cohen Madrigal Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 93,571 shares of MDGL stock, worth $26.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
93,571Holding current value
$26.2 Million% of portfolio
0.06%Shares
17 transactions
Others Institutions Holding MDGL
# of Institutions
313Shares Held
20MCall Options Held
824KPut Options Held
1.04M-
Janus Henderson Group PLC London, X02.6MShares$729 Million0.39% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$552 Million6.66% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.94MShares$545 Million6.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.78MShares$497 Million34.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$468 Million0.01% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.79B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...